- Home
- SENS vs CATX Comparison
SENS vs CATX Comparison
Compare SENS & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SENS
- CATX
- Stock Information
- Founded
- SENS 1996
- CATX 1983
- Country
- SENS United States
- CATX United States
- Employees
- SENS N/A
- CATX N/A
- Industry
- SENS Industrial Machinery/Components
- CATX Medical/Dental Instruments
- Sector
- SENS Industrials
- CATX Health Care
- Exchange
- SENS Nasdaq
- CATX Nasdaq
- Market Cap
- SENS 255.8M
- CATX 239.0M
- IPO Year
- SENS N/A
- CATX N/A
- Fundamental
- Price
- SENS $6.01
- CATX $2.29
- Analyst Decision
- SENS Strong Buy
- CATX Strong Buy
- Analyst Count
- SENS 6
- CATX 10
- Target Price
- SENS $25.58
- CATX $12.20
- AVG Volume (30 Days)
- SENS 537.3K
- CATX 1.8M
- Earning Date
- SENS 11-05-2025
- CATX 11-10-2025
- Dividend Yield
- SENS N/A
- CATX N/A
- EPS Growth
- SENS N/A
- CATX N/A
- EPS
- SENS N/A
- CATX N/A
- Revenue
- SENS $29,298,000.00
- CATX $1,075,000.00
- Revenue This Year
- SENS $63.07
- CATX N/A
- Revenue Next Year
- SENS $73.56
- CATX N/A
- P/E Ratio
- SENS N/A
- CATX N/A
- Revenue Growth
- SENS 31.94
- CATX N/A
- 52 Week Low
- SENS $5.00
- CATX $1.60
- 52 Week High
- SENS $28.00
- CATX $7.95
- Technical
- Relative Strength Index (RSI)
- SENS 57.74
- CATX 36.33
- Support Level
- SENS $5.51
- CATX $2.00
- Resistance Level
- SENS $6.59
- CATX $2.31
- Average True Range (ATR)
- SENS 0.45
- CATX 0.18
- MACD
- SENS -0.31
- CATX 0.01
- Stochastic Oscillator
- SENS 27.19
- CATX 34.61
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.